Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Influenza Vaccine Market , by Region, 2019-2027 (USD Billion)
1.2.2. Influenza Vaccine Market , by Vaccine Type, 2019-2027 (USD Billion)
1.2.3. Influenza Vaccine Market , by Type, 2019-2027 (USD Billion)
1.2.4. Influenza Vaccine Market , by Technology, 2019-2027 (USD Billion)
1.2.5. Influenza Vaccine Market , by Age Group, 2019-2027 (USD Billion)
1.2.6. Influenza Vaccine Market , by Route Of Administration, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Influenza Vaccine Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Influenza Vaccine Market Dynamics
3.1. Influenza Vaccine Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. High prevalence of influenza
3.1.1.2. Increase in government focus on immunization programs
3.1.2. Market Restraint
3.1.2.1. High costs associated with the development of vaccines
3.1.3. Market Opportunities
3.1.3.1. High growth prospects in emerging markets
Chapter 4. Global Influenza Vaccine Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Influenza Vaccine Market , by Vaccine Type
5.1. Market Snapshot
5.2. Global Influenza Vaccine Market by Vaccine Type , Performance - Potential Analysis
5.3. Global Influenza Vaccine Market Estimates & Forecasts by Vaccine Type 2018-2027 (USD Billion)
5.4. Influenza Vaccine Market , Sub Segment Analysis
5.4.1. Quadrivalent
5.4.2. Trivalent
Chapter 6. Global Influenza Vaccine Market , by Type
6.1. Market Snapshot
6.2. Global Influenza Vaccine Market by Type, Performance - Potential Analysis
6.3. Global Influenza Vaccine Market Estimates & Forecasts by Type 2018-2027 (USD Billion)
6.4. Influenza Vaccine Market , Sub Segment Analysis
6.4.1. Seasonal
6.4.2. Pandemic
Chapter 7. Global Influenza Vaccine Market , by Technology
7.1. Market Snapshot
7.2. Global Influenza Vaccine Market by Technology, Performance - Potential Analysis
7.3. Global Influenza Vaccine Market Estimates & Forecasts by Technology 2018-2027 (USD Billion)
7.4. Influenza Vaccine Market , Sub Segment Analysis
7.4.1. Egg-based
7.4.2. Cell-based
Chapter 8. Global Influenza Vaccine Market , by Age Group
8.1. Market Snapshot
8.2. Global Influenza Vaccine Market by Age Group, Performance - Potential Analysis
8.3. Global Influenza Vaccine Market Estimates & Forecasts by Age Group 2018-2027 (USD Billion)
8.4. Influenza Vaccine Market , Sub Segment Analysis
8.4.1. Pediatric
8.4.2. Adult
Chapter 9. Global Influenza Vaccine Market , by Route Of Administration
9.1. Market Snapshot
9.2. Global Influenza Vaccine Market by Route Of Administration, Performance - Potential Analysis
9.3. Global Influenza Vaccine Market Estimates & Forecasts by Route Of Administration 2018-2027 (USD Billion)
9.4. Influenza Vaccine Market , Sub Segment Analysis
9.4.1. Injection
9.4.2. Nasal Spray
Chapter 10. Global Influenza Vaccine Market , Regional Analysis
10.1. Influenza Vaccine Market , Regional Market Snapshot
10.2. North America Influenza Vaccine Market
10.2.1. U.S. Influenza Vaccine Market
10.2.1.1. Vaccine Type breakdown estimates & forecasts, 2018-2027
10.2.1.2. Type breakdown estimates & forecasts, 2018-2027
10.2.1.3. Technology breakdown estimates & forecasts, 2018-2027
10.2.1.4. Age Group breakdown estimates & forecasts, 2018-2027
10.2.1.5. Route Of Administration breakdown estimates & forecasts, 2018-2027
10.2.2. Canada Influenza Vaccine Market
10.3. Europe Influenza Vaccine Market Snapshot
10.3.1. U.K. Influenza Vaccine Market
10.3.2. Germany Influenza Vaccine Market
10.3.3. France Influenza Vaccine Market
10.3.4. Spain Influenza Vaccine Market
10.3.5. Italy Influenza Vaccine Market
10.3.6. Rest of Europe Influenza Vaccine Market
10.4. Asia-Pacific Influenza Vaccine Market Snapshot
10.4.1. China Influenza Vaccine Market
10.4.2. India Influenza Vaccine Market
10.4.3. Japan Influenza Vaccine Market
10.4.4. Australia Influenza Vaccine Market
10.4.5. South Korea Influenza Vaccine Market
10.4.6. Rest of Asia Pacific Influenza Vaccine Market
10.5. Latin America Influenza Vaccine Market Snapshot
10.5.1. Brazil Influenza Vaccine Market
10.5.2. Mexico Influenza Vaccine Market
10.6. Rest of The World Influenza Vaccine Market
Chapter 11. Competitive Intelligence
11.1. Top Market Strategies
11.2. Company Profiles
11.2.1. AstraZeneca plc.
11.2.1.1. Key Information
11.2.1.2. Overview
11.2.1.3. Financial (Subject to Data Availability)
11.2.1.4. Vaccine Type Summary
11.2.1.5. Recent Developments
11.2.2. Biodiem,
11.2.3. CSL Limited
11.2.4. Emergent BioSolutions
11.2.5. F. Hoffmann-La Roche Ltd.
11.2.6. Gamma Vaccines Pty Ltd.
11.2.7. GlaxoSmithKline plc
11.2.8. Merck & Co. Inc. (Merck Sharp & Dohme Corp.)
11.2.9. Novartis AG
11.2.10. Pfizer, Inc.
Chapter 12. Research Form
12.1. Research Form
12.1.1. Data Mining
12.1.2. Analysis
12.1.3. Market Estimation
12.1.4. Validation
12.1.5. Publishing
12.2. Research Attributes
12.3. Research Assumption